Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

November 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

insulin glulisine

"* Once Daily Insulin: Subjects will receive insulin glulisine administered once daily 0-15 minutes before the greatest glycemic impact meal of the day starting at one-tenth the total dose of insulin glargine with maximum starting dose of 10 Units, and with additional monitoring as shown in the table below.~* Twice Daily: Subjects will receive insulin glulisine administered twice daily 0-15 minutes before the 2 greatest glycemic impact meals of the day starting at one-tenth the total dose of insulin glargine with a maximum starting dose of 10 Units, and with additional monitoring as shown in the table below.~* Three Times Daily: Subjects will receive insulin glulisine administered 3 times daily 0-15 minutes before each meal of the day starting at one-tenth the total dose of insulin glargine with a maximum starting dose of 10 Units for each meal and additional monitoring as shown in the table below."

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY